Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer

A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer This combination of Oxigem effective in unresectable GBC. It may even induce complete pathological response. One-year survival was 20%. There is a need for controlled trial to assess efficacy of this combination. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Chemotherapy and Pharmacology Springer Journals

Loading next page...
 
/lp/springer-journals/a-phase-ii-study-of-gemcitabine-and-oxaliplatin-oxigem-in-unresectable-tihfYd35Rn

References (28)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Springer-Verlag
Subject
Medicine & Public Health; Oncology ; Cancer Research ; Pharmacology/Toxicology
ISSN
0344-5704
eISSN
1432-0843
DOI
10.1007/s00280-009-1055-0
pmid
19575200
Publisher site
See Article on Publisher Site

Abstract

This combination of Oxigem effective in unresectable GBC. It may even induce complete pathological response. One-year survival was 20%. There is a need for controlled trial to assess efficacy of this combination.

Journal

Cancer Chemotherapy and PharmacologySpringer Journals

Published: Feb 1, 2010

There are no references for this article.